Balance Sheet
Cash Flow Statement
Amortizatization of IntangiblesAsset Writedowns and ImpairmentBeginning Cash BalanceCapital ExpendituresCash from Investing ActivitiesCash from OperationsChange in Account PayablesChange in Accured ExpensesChange in CashChange in InventoryChange in ReceivablesDepreciation & Amortization (CF)Depreciation and DepletionFree Cash FlowGains from Investment SecuritiesGains from Sales and DivestituresNet Cash FlowNet IncomeNon-cash ItemsOther Working Capital ChangesShare-based Compensation
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Biofrontera (BFRI) Net Cash Flow: 2021-2025

Historic Net Cash Flow for Biofrontera (BFRI) over the last 5 years, with Sep 2025 value amounting to -$3.8 million.

  • Biofrontera's Net Cash Flow fell 144.62% to -$3.8 million in Q3 2025 from the same period last year, while for Sep 2025 it was -$8.0 million, marking a year-over-year decrease of 1227.88%. This contributed to the annual value of $4.5 million for FY2024, which is 128.56% up from last year.
  • As of Q3 2025, Biofrontera's Net Cash Flow stood at -$3.8 million, which was down 23.18% from -$3.1 million recorded in Q2 2025.
  • Over the past 5 years, Biofrontera's Net Cash Flow peaked at $22.8 million during Q4 2021, and registered a low of -$10.4 million during Q4 2022.
  • In the last 3 years, Biofrontera's Net Cash Flow had a median value of -$2.1 million in 2023 and averaged -$2.1 million.
  • In the last 5 years, Biofrontera's Net Cash Flow plummeted by 12,627.16% in 2023 and then spiked by 246.31% in 2024.
  • Over the past 5 years, Biofrontera's Net Cash Flow (Quarterly) stood at $22.8 million in 2021, then slumped by 145.37% to -$10.4 million in 2022, then skyrocketed by 79.88% to -$2.1 million in 2023, then soared by 246.31% to $3.0 million in 2024, then slumped by 144.62% to -$3.8 million in 2025.
  • Its Net Cash Flow was -$3.8 million in Q3 2025, compared to -$3.1 million in Q2 2025 and -$4.1 million in Q1 2025.